SciFluor Kicks Off With $5M

SciFluor Life Sciences, a Boston-based developer of technology for adding fluorine to organic molecules such as pharmaceutical drugs and commercial chemicals, launched today with $5 million in funding from Allied Minds. The technology, which helps make molecules more stable, potent, and better able to penetrate the blood-brain barrier, comes from Harvard University’s professor Tobias Ritter and others in the school’s department of chemistry and chemical biology. SciFluor has an exclusive license on fluorination technology and a group of novel fluorinated compounds from Harvard.

Trending on Xconomy